Keith Berman, the CEO of Decision Diagnostics Corporation (DECN), was arraigned for securities scams after investors purchased stock in his company hoping to benefit from an advanced COVID-19 test which, in reality, did not exist.
Berman declared that his business had actually developed a test that might detect COVID-19 from a drop of blood within 15 seconds. Berman informed financiers by means of press releases that the test would be all set for the business market in the summer season of 2020 and raised millions of dollars in funds to support the product.
iStock/Getty
The Korean supplier that Berman had utilized to establish the test informed Berman that the innovation used in the testing package could not in fact discover COVID-19
Using the alias “plutoniumimplosion,” Berman presumably hyped DECN on internet forums to offer false information to investors.
Berman was charged with one count of securities fraud and one count of making incorrect statements.
Blood-testing chicanery likewise led to the closure of Theranos, which declared to have technology that could carry out any blood test with a sample only consisting of a few drops of blood. After reports appeared that the innovation did not live up to the company’s claims, potentially offering inaccurate test outcomes, Theranos closed its doors in 2018.
Theranos founder Elizabeth Holmes and previous Theranos CEO Ramesh Balwani were charged with 2 counts of conspiracy to dedicate wire scams and 9 counts of wire fraud in 2018.
https://allcnaprograms.com/ceo-charged-with-fraud-in-15-second-covid-test-plan/
No comments:
Post a Comment